Index of reports
> Death (45)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 45 Next >>
Possible Magnevist side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male
Reactions: Joint Contracture, Skin Disorder, Muscular Weakness, Hypoaesthesia, Skin Induration, Nephrogenic Systemic Fibrosis, Muscle Rigidity, Balance Disorder, Grip Strength Decreased, Musculoskeletal Stiffness, Oedema, Depression, Gait Disturbance, Asthenia, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-09-27
End date: 2006-09-27
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Start date: 2003-11-28
End date: 2003-11-28
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-11-20
End date: 2006-11-20
Gadolinium IN Unspecified Drug
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-01
End date: 2006-02-01
Magnevist
Indication: Pancreatic Mass
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-08-06
Other drugs received by patient: Nephrocaps; Gabapentin; Phoslo; Toprol-XL; Reglan; Warfarin Sodium; Allopurinol; Insulin; Prevacid; Simvastatin
Possible Magnevist side effects in 50 year old female
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)
Reactions: Pain, Skin Induration, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Rash, Anxiety, Emotional Distress, Anhedonia, Skin Discolouration, Post Thrombotic Syndrome, Skin Mass, Ocular Icterus, Injury, Depression, Mobility Decreased
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Cardiac Imaging Procedure
Start date: 2003-08-12
End date: 2003-08-12
Magnevist
Dosage: unk
Indication: Renal Scan
Start date: 2003-08-07
End date: 2003-08-07
Magnevist
Dosage: unk
Start date: 2004-02-03
End date: 2004-02-03
Other drugs received by patient: Clonidine; Sodium Bicarbonate; Calcium Carbonate; Lopressor; Sevelamer Hydrochloride; Atorvastatin; Warfarin Sodium; Rapamune; Epogen; Diltiazem; Benicar
Possible Magnevist side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: male
Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Mobility Decreased, Extremity Contracture
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2006-11-13
Magnevist
Other drugs received by patient: Hectorol; Coumadin; Metoclopramide; Aspirin; Klor-CON
Possible Magnevist side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 61 year old male, weighing 124.0 kg (272.8 pounds)
Reactions: Wheelchair User, Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Paraesthesia, Skin Tightness, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia, Extremity Contracture, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: 15 ml (daily dose), once,
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-08-11
End date: 2000-08-11
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-01-01
End date: 2005-01-01
Magnevist
Dosage: 15 ml (daily dose), once,
Start date: 2001-07-27
End date: 2001-07-27
Other drugs received by patient: Nephrocaps; Phoslo; Metronidazole; Renagel; Coreg; Prinivil; Atenolol; Warfarin Sodium; Darvocet; Vancocin Hydrochloride; Sodium Bicarbonate; Iron [iron]; Amoxicillin; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Hydrocodone Bitartrate and Acetaminophen; Tylenol with Codein #3; Phoslo; Solivito N [vit C,vit H,b12,b9,b3,pantothenic Ac,b6,b2,b1 Hcl]; Aspirin; Vitamin B6; Coreg; Epogen; Diltiazem; Plendil; Plendil; Lisinopril
Possible Magnevist side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: 58 year old male, weighing 118.0 kg (259.6 pounds)
Reactions: Skin Exfoliation, Quality of Life Decreased, Pain, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Injury, Fibrosis, Blood Creatinine Increased, Extremity Contracture, Blister, Muscle Contracture, Rash Papular, Contrast Media Reaction, Skin Disorder, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Deformity, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Burning Sensation, Renal Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Other drugs received by patient: Calcium Acetate; Irbesartan; Clonidine; Hydralazine HCL; Visipaque; Visipaque; Glipizide; Ferrous Sulfate TAB; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Metoprolol Tartrate; Sevelamer Hydrochloride; Terazosin Hydrochloride; Dovonex; Contrast Media; Contrast Media; Synthroid; Aspirin; Felodipine; Contrast Media; Lasix; Omniscan; Folic Acid; Iron; Insulin; EPO
Possible Magnevist side effects in male
Reported by a lawyer from United States on 2012-08-14
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Nephrogenic Systemic Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Prohance
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-10-16
End date: 2002-10-16
Contrast Media
Indication: Diabetic Foot
Start date: 2002-11-05
End date: 2002-11-05
Magnevist
Dosage: once
Start date: 2002-11-15
End date: 2002-11-15
Magnevist
Dosage: once
Start date: 2004-07-16
End date: 2004-07-16
Contrast Media
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: once
Indication: Angiogram
Start date: 2005-01-25
End date: 2005-01-25
Contrast Media
Start date: 2005-01-14
End date: 2005-01-14
Contrast Media
Indication: Osteomyelitis
Start date: 2002-11-05
End date: 2002-11-05
Other drugs received by patient: Accupril; Epogen; Diatx; Fosrenol; Clonidine; Insulin Human; Temazepam; Sevelamer Hydrochloride; Vitamins NOS; Insulin; Coumadin; Minoxidil; Lasix; Calcium Acetate
Possible Magnevist side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Gadolinium IN Unspecified Drug
Indication: Osteomyelitis
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Diabetic Foot
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-01-14
End date: 2005-01-14
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix
Possible Magnevist side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-08
Patient: male
Reactions: Pain, Abasia, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Grip Strength Decreased, Skin Fibrosis, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-11-13
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Renal Transplant
Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin
Possible Magnevist side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: male
Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Omniscan
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2006-11-13
Other drugs received by patient: Coumadin; Aspirin; Klor-CON; Metoclopramide; Hectorol
Possible Magnevist side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)
Reactions: Pain, Skin Induration, Nephrogenic Systemic Fibrosis, Scleroderma, Rash, Skin Hyperpigmentation, Emotional Distress, Anxiety, Skin Discolouration, Skin Mass, Injury, Scleral Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-08-12
End date: 2003-08-12
Magnevist
Dosage: unk
Indication: Cardiac Imaging Procedure
Start date: 2003-08-07
End date: 2003-08-07
Magnevist
Dosage: unk
Indication: Renal Scan
Start date: 2003-08-07
End date: 2003-08-07
Magnevist
Dosage: unk
Start date: 2004-02-03
End date: 2004-02-03
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-02-03
End date: 2004-02-03
Magnevist
Dosage: unk
Start date: 2003-08-12
End date: 2003-08-12
Other drugs received by patient: Warfarin; Lopressor; Sevelamer; Benicar; Atorvastatin; Rapamune; Diltiazem; Calcium Carbonate; Clonidine; Sodium Bicarbonate; Epogen
Possible Magnevist side effects in 47 year old female
Reported by a consumer/non-health professional from United States on 2012-07-24
Patient: 47 year old female
Reactions: Vomiting, Dyspnoea, Nausea, Unresponsive To Stimuli, Cardiac Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Possible Magnevist side effects in 79 year old female
Reported by a physician from United States on 2012-07-20
Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Dosage: dose reported as eight 20ml vials (160ml)
Start date: 2005-09-20
End date: 2005-09-20
Multihance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Multihance
Indication: Angiogram
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Gadolinium Zeolite
Start date: 2005-08-16
End date: 2005-08-16
Omniscan
Dosage: route reported as ^first via distal port and then via the proximal port^
Indication: Angiogram
Start date: 2003-12-04
End date: 2003-12-04
Optimark
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2005-08-16
End date: 2005-08-16
Optimark
Indication: Angiogram
Gadolinium Zeolite
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2001-03-05
End date: 2001-03-05
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-05-23
End date: 2003-05-23
Prohance
Indication: Angiogram
Magnevist
Indication: Angiogram
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: dose reported as ^11^ 20ml vials
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-01
End date: 2005-09-01
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar
Possible Magnevist side effects in
Reported by a consumer/non-health professional from United States on 2012-06-26
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Possible Magnevist side effects in 52 year old female
Reported by a physician from Japan on 2012-06-21
Patient: 52 year old female, weighing 35.0 kg (77.0 pounds)
Reactions: Pneumonia, Nephrogenic Systemic Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Start date: 2004-07-07
End date: 2004-07-07
Omniscan
Start date: 2005-09-09
End date: 2005-09-09
Omniscan
Start date: 2005-12-21
End date: 2005-12-21
Omniscan
Dosage: 7 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-24
End date: 2003-09-24
Magnevist
Dosage: 7 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-05-14
End date: 2003-05-14
Omniscan
Start date: 2005-08-03
End date: 2005-08-03
Magnevist
Indication: Aortic Stenosis
Start date: 2004-03-17
End date: 2004-03-17
Magnevist
Dosage: 15 ml, once
Start date: 2005-08-30
End date: 2005-08-30
Magnevist
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: 15 ml, once
Start date: 2005-05-25
End date: 2005-05-25
Magnevist
Dosage: 15 ml, once
Start date: 2004-12-29
End date: 2004-12-29
Magnevist
Indication: Angiogram
Start date: 2003-07-08
End date: 2003-07-08
Omniscan
Start date: 2003-11-26
End date: 2003-11-26
Omniscan
Start date: 2005-03-16
End date: 2005-03-16
Other drugs received by patient: Lidocaine; Levothyroxine Sodium; Pursennide; Prednisolone; Losartan Potassium; Diastase; Heparin Calcium; Lansoprazole; Pursennide; Levothyroxine Sodium; Renagel
Possible Magnevist side effects in 50 year old female
Reported by a consumer/non-health professional from United States on 2012-06-06
Patient: 50 year old female
Reactions: Anxiety, Emotional Distress, Pain, Nephrogenic Systemic Fibrosis, Injury
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-08-07
End date: 2003-08-07
Magnevist
Dosage: unk
Start date: 2004-02-03
End date: 2004-02-03
Magnevist
Dosage: unk
Start date: 2003-08-12
End date: 2003-08-12
Possible Magnevist side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Emotional Distress, Pruritus Generalised, Anxiety, Anhedonia, Pain, Nephrogenic Systemic Fibrosis, Injury, Deformity, Scar
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2006-03-01
End date: 2008-03-01
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-30
End date: 2006-01-30
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-26
End date: 2006-03-26
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-03-29
End date: 2006-03-29
Other drugs received by patient: Hectorol; Losartan; Diovan; Epogen; Renagel; Metoprolol Tartrate
Possible Magnevist side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)
Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Arthralgia, Gait Disturbance, Skin Fibrosis, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: 30 ml, once
Start date: 2000-05-05
End date: 2000-05-05
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Start date: 2006-07-14
End date: 2006-07-14
Magnevist
Dosage: 48 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-02-05
End date: 2000-02-05
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-12-17
End date: 2001-12-17
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 39 ml, once
Start date: 2006-07-26
End date: 2006-07-26
Unspecified Gadolinium Based Contrast Agent
Indication: Angiogram
Start date: 2000-10-01
End date: 2000-10-15
Magnevist
Dosage: 40 ml, once
Start date: 2006-08-09
End date: 2006-08-09
Other drugs received by patient: Prednisone; Imuran; Norvasc; Calcium Carbonate; Micardis; Oxycet; Darbepoetin Alfa; Minoxidil; Percocet; Renagel; Digoxin; Clonidine; Phoslo; Lanthanum Carbonate; Ferrlecit; Florinef; Lopressor; Plaquenil; Procardia; Zemplar; Coreg; Amiodarone HCL; Aspirin; Cortisone Acetate; Renaphro; Epogen; Vancomycin; Darbepoetin Alfa; Hectorol; Fosrenol
Possible Magnevist side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)
Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Muscular Weakness, General Physical Health Deterioration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Arthralgia, Gait Disturbance, Mobility Decreased, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Unspecified Gadolinium Based Contrast Agent
Indication: Angiogram
Start date: 2000-10-01
End date: 2000-10-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-12-17
End date: 2001-12-17
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 48 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-02-05
End date: 2000-02-05
Magnevist
Dosage: 39 ml, once
Start date: 2006-07-26
End date: 2006-07-26
Magnevist
Dosage: 30 ml, once
Start date: 2000-05-05
End date: 2000-05-05
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 40 ml, once
Start date: 2006-08-09
End date: 2006-08-09
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Start date: 2006-07-14
End date: 2006-07-14
Other drugs received by patient: Epogen; Renagel; Procardia; Aspirin; Lopressor; Minoxidil; Ferrlecit; Zemplar; Coreg; Norvasc; Calcium Carbonate; Lanthanum Carbonate; Renaphro; Imuran; Digoxin; Florinef; Cortisone Acetate; Plaquenil; Micardis; Amiodarone HCL; Darbepoetin Alfa; Prednisone; Hectorol; Vancomycin; Darbepoetin Alfa; Phoslo; Fosrenol; Clonidine; Percocet; Oxycet
Possible Magnevist side effects in 69 year old male
Reported by a physician from United States on 2012-05-08
Patient: 69 year old male, weighing 99.0 kg (217.8 pounds)
Reactions: Pruritus, Joint Contracture, Pain, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Fibrosis, Extremity Contracture, Peau D'orange, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Tightness, Burning Sensation, Gait Disturbance, Asthenia, Cardiovascular Disorder, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Back Pain
Start date: 2001-03-20
End date: 2001-03-20
Magnevist
Dosage: 10 ml, unk
Indication: Angioplasty
Start date: 2002-10-02
End date: 2002-10-02
Prohance
Indication: Angiogram
Magnevist
Dosage: 10 ml, unk
Start date: 2004-12-02
End date: 2004-12-02
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2002-02-04
End date: 2002-02-04
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2001-05-17
End date: 2001-05-17
Omniscan
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 10 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-25
End date: 2006-08-25
Magnevist
Dosage: 20 ml, unk
Indication: Stent Placement
Start date: 2003-05-14
End date: 2003-05-14
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-03-27
End date: 2002-03-27
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 20 ml, unk
Start date: 2002-09-09
End date: 2002-09-09
Magnevist
Dosage: 20 ml, unk
Start date: 2004-10-19
End date: 2004-10-19
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Potassium Chloride; Cardura; Aspirin; Norvasc; Demadex; Zetia; Spironolactone; Clonidine; Diltiazem; Epogen; Isosorbide Dinitrate; Quinine Sulfate; Lisinopril; Minoxidil; Nephrocaps
Possible Magnevist side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)
Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hyperpigmentation, Hypoaesthesia, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Prohance
Indication: Diagnostic Procedure
Magnevist
Indication: Diagnostic Procedure
Optimark
Indication: Diagnostic Procedure
Multihance
Indication: Diagnostic Procedure
Omniscan
Indication: Diagnostic Procedure
Contrast Media
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Xalatan; Multivitamins and Iron; Colchicine; Aspirin; Lotrel; Meloxicam; Alphagan; Cosopt; Plavix; Hydrochlorothiazide; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lovenox
Possible Magnevist side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)
Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Hypoaesthesia, Skin Hyperpigmentation, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Indication: Diagnostic Procedure
Multihance
Indication: Diagnostic Procedure
Contrast Media
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Diagnostic Procedure
Omniscan
Indication: Diagnostic Procedure
Prohance
Indication: Diagnostic Procedure
Other drugs received by patient: Plavix; Hydrochlorothiazide; Xalatan; Meloxicam; Colchicine; Aspirin; Lovenox; Cosopt; Alphagan; Multivitamins and Iron; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lotrel
Possible Magnevist side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Pain, Joint Contracture, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Hypertrophy, Muscle Rigidity, Emotional Distress, Anxiety, Anhedonia, Impaired Healing, Musculoskeletal Stiffness, Injury, Disability, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 1999-11-12
End date: 1999-11-12
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-07-31
End date: 2001-07-31
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1998-01-15
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2000-06-30
End date: 2000-06-30
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 1997-11-06
End date: 1997-11-06
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1995-10-02
Other drugs received by patient: Sensipar; Nephrocaps; Toprol-XL; Warfarin Sodium; Lasix; Renagel; MAG-TAB; Prednisone TAB; Iron; Norvasc; Procardia; Inderal; Vasotec; Coumadin; Minoxidil; Lisinopril; Buspar; Midodrine Hydrochloride; Epogen; Immunosuppressive Agents; Digoxin; Lexapro; Fosrenol
Possible Magnevist side effects in female
Reported by a physician from Japan on 2012-04-23
Patient: female
Reactions: Lymphocyte Percentage Decreased, Lymphadenopathy, Pyrexia, Erythema, Liver Disorder, LIP Erosion, Death, C-Reactive Protein Increased, Oral Mucosa Erosion, White Blood Cell Count Increased, Stevens-Johnson Syndrome, Neutrophil Percentage Increased, Vomiting, Rash Generalised, Cytomegalovirus Enterocolitis, Alanine Aminotransferase Increased, Drug Rash With Eosinophilia and Systemic Symptoms, Vulvar Erosion, Diarrhoea, Ocular Hyperaemia, Aspartate Aminotransferase Increased, Rash Maculo-Papular
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Lamictal
Dosage: 100mg per day
Administration route: Oral
Start date: 2011-11-24
End date: 2011-12-17
Magnevist
Dosage: 15ml per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-16
End date: 2011-12-16
Lamictal
Dosage: 50mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-11-14
End date: 2011-11-23
Phenytoin Sodium CAP
Dosage: 250mg per day
Indication: Epilepsy
Start date: 2011-11-13
End date: 2011-11-13
Tegretol
Dosage: 200mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-11-13
End date: 2011-11-14
Possible Magnevist side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Other drugs received by patient: Coumadin; Temazepam; Procrit; Fosrenol; Minoxidil; Novolin R; Insulin [insulin]; Phoslo; Diatx; Vitamins NOS; Accupril; Lasix; Clonidine; Renagel
Possible Magnevist side effects in male
Reported by a physician from United States on 2012-03-22
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Nephrogenic Systemic Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-10-16
End date: 2002-10-16
Contrast Media
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: once
Indication: Angiogram
Start date: 2005-01-25
End date: 2005-01-25
Magnevist
Dosage: once
Start date: 2002-11-15
End date: 2002-11-15
Magnevist
Dosage: once
Start date: 2004-07-16
End date: 2004-07-16
Prohance
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Other drugs received by patient: Insulin Human; Calcium Acetate; Coumadin; Insulin; Temazepam; Clonidine; Diatx; Lasix; Epogen; Sevelamer; Vitamins NOS; Fosrenol; Minoxidil; Accupril
Possible Magnevist side effects in 20 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21
Patient: 20 year old male, weighing 48.6 kg (106.9 pounds)
Reactions: Skin Exfoliation, Hypertrophy, Joint Contracture, Pain, Abasia, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Depression, Joint Effusion, Extremity Contracture, Pain in Extremity, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Cachexia, Joint Warmth, Asthenia, Mobility Decreased
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-01-21
End date: 2006-01-21
Omniscan
Dosage: 30 ml, once
Indication: Angiogram
Start date: 2005-06-02
End date: 2005-06-02
Omniscan
Other drugs received by patient: Enoxaparin; Labetalol HCL; Norvasc; Dantrolene Sodium; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Clonidine HCL; Darbepoetin Alfa; Hydralazine HCL; Fluoxetine; Cefazolin; Renagel; Coumadin
Possible Magnevist side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-20
Patient: female
Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Scar, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Magnevist
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Possible Magnevist side effects in 53 year old female
Reported by a pharmacist from United States on 2012-03-19
Patient: 53 year old female, weighing 114.7 kg (252.4 pounds)
Reactions: Pruritus, Pain, Erythema, Anhedonia, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Injury, Pain in Extremity, Localised Oedema, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Activities of Daily Living Impaired, Skin Mass, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Xopenex; Vasotec; Demedex; Enalapril; Sensipar; Astelin; Phoslo; Vasopressin; Humulin N; Zelnorm; Ativan; Wellbutrin XL; Aspirin; Santyl; Norco; Keppra; Avandia; Allopurinol; Epogen; Aspirin; Torsemide; Neurontin; Hydrocodone Bitartrate and Acetaminophen; Synthroid; Regular Insulin; Renagel; NPH Insulin; Atrovent; Zyloprim; Mirapex; Glucotrol; Ibuprofen
Possible Magnevist side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-28
Patient: 69 year old male, weighing 99.0 kg (217.8 pounds)
Reactions: Pruritus, Pain, Joint Contracture, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Fibrosis, Extremity Contracture, Peau D'orange, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Tightness, Burning Sensation, Gait Disturbance, Asthenia, Cardiovascular Disorder, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2001-05-17
End date: 2001-05-17
Magnevist
Dosage: 20 ml, unk
Indication: Stent Placement
Start date: 2003-05-14
End date: 2003-05-14
Magnevist
Dosage: 10 ml, unk
Start date: 2004-12-02
End date: 2004-12-02
Omniscan
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-03-27
End date: 2002-03-27
Magnevist
Dosage: 10 ml, unk
Indication: Angioplasty
Start date: 2002-10-02
End date: 2002-10-02
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 20 ml, unk
Start date: 2002-09-09
End date: 2002-09-09
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Magnevist
Dosage: 10 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-25
End date: 2006-08-25
Magnevist
Dosage: 20 ml, unk
Start date: 2004-10-19
End date: 2004-10-19
Magnevist
Dosage: unk
Indication: Back Pain
Start date: 2001-03-20
End date: 2001-03-20
Prohance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2002-02-04
End date: 2002-02-04
Optimark
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Lisinopril; Cardura; Minoxidil; Demadex; Isosorbide Dinitrate
Possible Magnevist side effects in female
Reported by a lawyer from United States on 2012-02-27
Patient: female, weighing 93.4 kg (205.5 pounds)
Reactions: Pain, Skin Disorder, Laceration, Muscular Weakness, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Erythema, Skin Tightness, Arthralgia, Swelling, Musculoskeletal Stiffness, Oedema, Skin Fibrosis, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Humulin N; Monopril; Simvastatin; Coreg; Sular; Aspirin; Darvocet; Renagel
Page 1 Next >>
|